Oral Fluoroquinolones and the Risk of Retinal Detachment
1. Mahyar Etminan, PharmD, MSc (epi);
2. Farzin Forooghian, MD, MSc, FRCSC;
3. James M. Brophy, MD, PhD, FRCPC;
4. Steven T. Bird, PharmD;
5. David Maberley, MD, MSc, FRCSC
[+] Author Affiliations
1. Author Affiliations: Therapeutic Evaluation Unit, Child and Family Research Institute of British Columbia, Vancouver, Canada (DrEtminan); Departments of Medicine (DrEtminan) and Ophthalmology and Visual Sciences (DrsForooghian and Maberley), University of British Columbia, Vancouver, Canada; Departments of Epidemiology, Biostatistics, and Medicine, McGill University, Montreal, Quebec, Canada (DrBrophy); and US Food and Drug Administration, Center for Drug Evaluation and Research Office of Management, and Academic Collaboration Program, Silver Spring, Maryland (Dr Bird
|